Kawasumi Laboratories Inc. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2016 and Full Year of Fiscal Year Ending March 31, 2017
Kawasumi Laboratories Inc. announced consolidated earnings results for the first quarter ended June 30, 2016. For the period, the consolidated company reported net sales of ¥6,048 million, operating income of ¥309 million, ordinary income of ¥173 million, profit attributable to owners of the parent of ¥393 million or net income per share of ¥18.03 compared to net sales of ¥6,778 million, operating income of ¥365 million, ordinary income of ¥473 million, net income of ¥344 million or net income per share of ¥15.08 for the same period last year. Profit before income taxes was ¥170 million against ¥491 million a year ago. Net cash provided by operating activities was ¥778 million against ¥600 million a year ago. Purchase of property, plant and equipment was ¥616 million against ¥122 million a year ago. Purchase of intangible assets was ¥49 million against ¥14 million a year ago.
For the six months ending September 30, 2016, the company expects net sales of ¥12,500 million, operating income of ¥300 million, ordinary income of ¥300 million, profit attributable to owners of the parent of ¥500 million or net income per share of ¥22.92.
For the full year of fiscal year ending March 31, 2017, the company expects net sales of ¥25,700 million, operating income of ¥1,000 million, ordinary income of ¥1,000 million, profit attributable to owners of the parent of ¥1,100 million or net income per share of ¥50.42.